🇺🇸 FDA
Patent

US 10898451

Methods of treating anti-NMDA receptor encephalitis with tramadol

granted A61KA61K31/135A61K35/16

Quick answer

US patent 10898451 (Methods of treating anti-NMDA receptor encephalitis with tramadol) held by The Board of Regents of the University of Texas System expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/135, A61K35/16, A61K9/0019, A61P